Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.32
-0.15
(-2.74%)
At close: 4:00:01 PM EDT
5.00
-0.32
(-6.10%)
After hours: 5:31:55 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 4 |
Avg. Estimate | -0.24 | 0.61 | -0.17 | -0.55 |
Low Estimate | -0.3 | -0.26 | -1 | -0.68 |
High Estimate | -0.12 | 2.48 | 1.52 | -0.41 |
Year Ago EPS | -0.14 | -0.28 | -0.94 | -0.17 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 7 | 5 |
Avg. Estimate | -800k | 54.8M | 71M | 38.73M |
Low Estimate | -4M | -- | -- | 23M |
High Estimate | -- | 180M | 199.05M | 53.13M |
Year Ago Sales | -- | -- | -- | 71M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -45.45% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.11 | -0.14 | -0.26 | -0.22 |
EPS Actual | -0.14 | -0.28 | -0.25 | -0.27 |
Difference | -0.03 | -0.14 | 0.01 | -0.05 |
Surprise % | -32.29% | -97.94% | 3.64% | -24.25% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.24 | 0.61 | -0.17 | -0.55 |
7 Days Ago | -0.22 | -0.22 | -0.27 | -0.47 |
30 Days Ago | -0.22 | -0.22 | -0.34 | -0.11 |
60 Days Ago | -0.22 | -0.22 | -0.33 | -0.11 |
90 Days Ago | -0.22 | -0.22 | -0.43 | -0.2 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | 1 | 1 | 4 | 3 |
Down Last 30 Days | 1 | 1 | 4 | 3 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ALDX | -68.57% | 317.86% | 81.49% | -216.09% |
S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/9/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/2/2024 |
Reiterates | Oppenheimer: Outperform to Outperform | 5/6/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/6/2024 |
Upgrade | Oppenheimer: Perform to Outperform | 4/3/2024 |
Related Tickers
ABEO Abeona Therapeutics Inc.
4.6800
+5.17%
MIST Milestone Pharmaceuticals Inc.
0.8031
+5.67%
ATRA Atara Biotherapeutics, Inc.
6.13
+2.00%
CAPR Capricor Therapeutics, Inc.
9.74
+2.80%
ARDX Ardelyx, Inc.
4.8800
+1.88%
THTX Theratechnologies Inc.
1.4700
+5.00%
SCPH scPharmaceuticals Inc.
2.5000
+7.30%
KALV KalVista Pharmaceuticals, Inc.
11.09
-0.58%
ANVS Annovis Bio, Inc.
1.5900
+6.71%
URGN UroGen Pharma Ltd.
11.20
+5.36%